Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion

MLA

Kulik L, et al. “Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion.” Journal of Hepatocellular Carcinoma, vol. ume 7, Dec. 2020, pp. 423–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.562423561ec3484ca2419ceefe09a787&authtype=sso&custid=ns315887.

APA

Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, & Galle PR. (2020). Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion. Journal of Hepatocellular Carcinoma, ume 7, 423–433.

Chicago

Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, and Galle PR. 2020. “Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion.” Journal of Hepatocellular Carcinoma ume 7 (December): 423–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.562423561ec3484ca2419ceefe09a787&authtype=sso&custid=ns315887.